MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202611099293 A) filed by Noida International University on August 17, 2026, for Circadian-Responsive Thyroid Hormone Prodrug And Personalised Delivery System.
Inventors include Gunjan Nautiyal; Sapna Joshi; Abhilasha Singh; and Sameer Rastogi.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: The invention relates to a circadian-responsive thyroid-hormone prodrug for management of hypothyroidism. A thyroid-hormone payload comprising T4 or a T4/T3 dual payload is chemically connected to a biodegradable linker. The linker may comprise an esterase-cleavable carbamate or acylal bond and a biological-cloc...